Menu

Home / Guides / GLP-1 stomach side effects

From the drug labels.

GLP-1 Stomach Side Effects: Diarrhea, Nausea, Sulfur Burps and What Helps

By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD (NPI 1144260043) · Updated

GLP-1 medicines most often cause nausea, diarrhea, constipation and vomiting; burping, indigestion and heartburn are less common. In label trials, 56% of people on Zepbound and 73% on Wegovy had a stomach side effect, versus 30% and 47% on placebo. Most came while the dose was going up.

  • Most common: nausea, in 25–29% on Zepbound and 44% on Wegovy
  • What helps: small meals every 3 to 4 hours, fluids, less fat and alcohol
  • When to call: vomiting or diarrhea that won’t stop, or severe belly pain
Published by NexLifeLegitScript-certified

Most common, in the label trials

Nausea
25–29% on Zepbound, 44% on Wegovy
Diarrhea
19–23% on Zepbound, 30% on Wegovy
Constipation
11–17% on Zepbound, 24% on Wegovy
Vomiting
8–13% on Zepbound, 24% on Wegovy
Burping
4–5% on Zepbound, 7% on Wegovy

Stomach side effect bothering you? Call or text (949) 818-8000. Real people answer 24/7.

Check my eligibility

4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026) · LegitScript certified

About 3 minutes of health questions. No insurance needed.

Compounded medicines aren’t FDA-approved. A NexLife provider prescribes one only if it offers a significant difference for you compared with an FDA-approved medicine.

At a glance

What should you know about GLP-1stomach side effects?

The short answers, from the Zepbound and Wegovy labels and the 2025 joint nutrition advisory. Each one is explained below.

GLP-1 stomach side effects: the short answers, from the Zepbound prescribing information (revised August 2026), the Wegovy prescribing information (revised June 2026) and the 2025 joint nutrition advisory
QuestionAnswer
What’s most common?Nausea, diarrhea, constipation and vomiting. Burping, indigestion, reflux, gas and bloating are less common.
How many people get one?56% on Zepbound versus 30% on placebo; 73% on Wegovy versus 47% on placebo.
When do they start?Mostly while the dose is going up. On Zepbound, most nausea, vomiting and diarrhea then decreased over time.
What helps?Small meals every 3 to 4 hours, enough fluids, fewer large or high-fat meals, and very little alcohol.
When should you call?Vomiting or diarrhea that won’t stop, or severe belly pain that may reach your back.
What about compounded versions?They aren’t FDA-approved and weren’t studied in these trials. Dosing mistakes have caused stomach side effects, the FDA says.

These numbers come from trials of FDA-approved Zepbound and Wegovy. Compounded tirzepatide and semaglutide aren’t FDA-approved and weren’t studied in them.

  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Usually within 1 to 2 business days, free

Key takeaways

  • The big four: nausea, diarrhea, constipation and vomiting. Nausea affected 25% to 29% on Zepbound and 44% on Wegovy, versus 8% and 16% on placebo.
  • They come early: most start while the dose is going up. On Zepbound, most nausea, vomiting and diarrhea then decreased over time.
  • Burping and reflux are less common: burping affected 4% to 5% on Zepbound and 7% on Wegovy; acid reflux 4% to 5% and 5%.
  • Food changes help most: small meals every 3 to 4 hours, fluids, fiber added slowly, fewer high-fat meals and very little alcohol.
  • Severe belly pain that won’t go away? It can be pancreatitis: stop the medicine and call your provider right away.
  • At NexLife, real people answer 24/7 at (949) 818-8000. Compounded tirzepatide is $115 a month on the 12-month plan, paid upfront ($1,380), or $129 month to month.

How often

How common is each GLP-1 stomach side effect?

Nausea leads on both labels: 25% to 29% of people on Zepbound and 44% on Wegovy, versus 8% and 16% on placebo. Each drug was tested against its own placebo group, so read each row within its own trial.

Share of people with each stomach side effect in the label trials (%): Zepbound 5 mg to 15 mg and its placebo group; Wegovy 2.4 mg and its placebo group
Side effectZepbound 5–15 mg (%)Its placebo (%)Wegovy 2.4 mg (%)Its placebo (%)
Nausea25–2984416
Diarrhea19–2383016
Vomiting8–132246
Constipation11–1752411
Belly pain9–1052010
Indigestion (dyspepsia)9–10493
Burping (eructation)4–517Under 1
Acid reflux (GERD)4–5253
Gas (flatulence)3–4264
Bloating (abdominal distension)3–4275
Any stomach side effect56307347
Stopped because of one1.9–4.30.54.30.7

Zepbound: prescribing information, revised August 2026, Table 1 and section 6.1, two 72-week trials at 5 mg, 10 mg and 15 mg. Its diarrhea row includes frequent bowel movements, and its constipation row includes hard stools. Wegovy: prescribing information, revised June 2026, Table 3 and section 6.1, adults on 2.4 mg. The trials differed, so don’t compare the two drugs row by row.

Why it happens

Why do GLP-1 medicines upset your stomach?

GLP-1 medicines slow how fast food leaves your stomach, and the 2025 joint nutrition advisory links that slower emptying to bloating, fullness and nausea. Both labels list delayed stomach emptying.

“Tirzepatide delays gastric emptying. The delay is largest after the first dose and this effect diminishes over time.”

Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, revised August 2026

The advisory adds that higher doses are more likely to cause these symptoms. Both medicines start low and rise in steps, and Zepbound’s label and Wegovy’s label both say to follow those steps “to reduce the risk of gastrointestinal adverse reactions.”

What you eat matters too. Foods high in fat or protein can slow stomach emptying further, the advisory says, which may mean limiting very rich meals for a while. Our GLP-1 meal plan shows how to spread protein across small meals.

Both labels also say the medicine isn’t recommended for people with severe gastroparesis, a stomach that already empties very slowly.

How long

How long do GLP-1 stomach side effects last?

GLP-1 stomach side effects are most likely in the first months, while the dose is rising. On Zepbound, most nausea, vomiting and diarrhea came during dose increases and decreased over time; Wegovy’s stomach side effects were most often reported during dose increases.

  1. The starting dose: 2.5 mg of tirzepatide or 0.25 mg of semaglutide, once a week. Neither is a maintenance dose.

  2. Zepbound rises 2.5 mg at a time, after at least 4 weeks on each dose. Wegovy goes to 0.5 mg, 1 mg and 1.7 mg, 4 weeks each, then 2.4 mg from week 17; the label allows raising it to 7.2 mg.

  3. On Zepbound, nausea, vomiting and diarrhea decreased over time. Its effect on stomach emptying is largest after the first dose and fades.

  4. Your provider can slow things down. Wegovy’s label says to consider delaying a dose increase by 4 weeks; Zepbound’s allows a lower maintenance dose.

“The majority of nausea, vomiting, and/or diarrhea events occurred during dose escalation and decreased over time.”

Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, revised August 2026
  • 1.9–4.3%stopped Zepbound for a stomach side effect
  • 0.5%stopped its placebo
  • 4.3%stopped Wegovy for one
  • 0.7%stopped its placebo

Neither label gives a typical number of days a symptom lasts. On Zepbound, most people who stopped for side effects did so in the first few months, mainly for stomach side effects. Not easing after a dose step? Tell your provider. Back after a missed dose or a break? See restarting tirzepatide or restarting semaglutide.

Diarrhea

What helps GLP-1 diarrhea?

Fluids come first: diarrhea affected 19% to 23% of people on Zepbound and 30% on Wegovy, versus 8% and 16% on placebo, and both labels warn that dehydration from it can lead to kidney injury. Fewer high-fat meals and very little alcohol also help.

  • Drink enough

    Sip fluids through the day. Dehydration from severe nausea, vomiting or diarrhea can cause acute kidney injury, the advisory says, so work to prevent it.

  • Skip large or high-fat meals

    Avoiding large or high-fat meals can help, per the advisory. Regular, small meals are on its list to encourage.

  • Fiber for bulk

    If diarrhea is significant, fiber capsules or powders add bulk to the stool, the advisory says.

  • Short-term medicine

    Anti-diarrheal medicines can give short-term relief, per the advisory. Ask your provider or pharmacist which one fits your other medicines.

Call your provider if diarrhea won’t stop. Zepbound’s label tells patients to promptly report persistent nausea, vomiting or diarrhea. Most kidney-injury reports, some needing dialysis, came in people dehydrated by these symptoms.

Nausea and vomiting

What helps nausea and vomiting on a GLP-1?

Small, regular meals help most: the 2025 joint nutrition advisory suggests a small breakfast, then small meals every 3 to 4 hours, with enough fluids. Nausea affected 25% to 29% on Zepbound and 44% on Wegovy; vomiting 8% to 13% and 24%.

  1. Eat small, and often. A small breakfast, then small meals every 3 to 4 hours. Vomiting is more likely after large meals, the advisory says.
  2. Don’t skip meals. Some people stop eating because they feel sick, which makes nausea worse. Long stretches without food are on the advisory’s list to avoid.
  3. Go easy on rich food early on. The advisory suggests smaller meals and avoiding fatty or high-fiber foods in the first few days of treatment.
  4. Try ginger or peppermint tea. The advisory lists both, along with acupressure bands.
  5. Ask about anti-nausea medicine. These can help while you adjust and around dose increases, the advisory says. Your provider decides which fits you.
  6. Keep alcohol to a minimum. Alcohol may worsen nausea and reflux on GLP-1 therapy, per the advisory. More: tirzepatide and alcohol, what the labels say.

Still sick after a dose step? Your provider can slow the schedule: Wegovy’s label says to consider delaying a dose increase for 4 weeks if a dose isn’t tolerated. A full day of small meals is in our GLP-1 meal plan. Feeling wiped out too? Why tirzepatide can make you tired.

Stomach side effect bothering you?

Call or text NexLife at (949) 818-8000, 24/7. A real person answers. We get your question to your provider, follow up with the pharmacy if it’s about your medicine, and get back to you with the next step.

Sulfur burps

Why do GLP-1s cause sulfur burps, and what helps?

Burping is a listed side effect of both medicines: 4% to 5% of people on Zepbound and 7% on Wegovy, versus 1% and under 1% on placebo. The labels count burping as one side effect, with no separate figure for sulfur-smelling burps, and the 2025 advisory gives no burp-specific advice.

What the sources do explain is the setting. GLP-1 medicines slow stomach emptying, which the advisory links to bloating, fullness and nausea. Related symptoms are on the labels too: indigestion affected 9% to 10% on Zepbound and 9% on Wegovy, and bloating 3% to 4% and 7%.

  • Smaller meals

    Large meals are on the advisory’s list to avoid; regular small meals at consistent times are on its list to encourage.

  • Less rich food, for now

    Foods high in fat or protein can slow stomach emptying further, the advisory says, which may mean limiting very rich meals for a while.

  • Very little alcohol

    Alcohol may worsen reflux and nausea on GLP-1 therapy, per the advisory.

  • Tell your provider

    Burping with severe or lasting belly pain or vomiting needs a call. Zepbound’s label says to contact your provider for severe or persistent stomach symptoms.

Before adding any medicine for gas or burping, ask your provider or pharmacist. Zepbound’s label notes that slower stomach emptying can affect how other oral medicines are absorbed.

Heartburn and reflux

Can GLP-1 medicines cause heartburn or acid reflux?

Yes, in a minority of people: acid reflux (GERD) affected 4% to 5% on Zepbound and 5% on Wegovy, versus 2% and 3% on placebo. Indigestion was more common, at 9% to 10% and 9%; both are less common than nausea, diarrhea, constipation and vomiting.

Heartburn-type side effects in the label trials (%): Zepbound 5 mg to 15 mg and Wegovy 2.4 mg, each with its own placebo group
Side effectZepbound (%)Its placebo (%)Wegovy (%)Its placebo (%)
Acid reflux (GERD)4–5253
Indigestion (dyspepsia)9–10493
Gastritis (irritated stomach lining)Not listed on Zepbound’s labelNot listed on Zepbound’s label41

The advisory names one reflux trigger to limit: alcohol, which may worsen reflux and nausea on GLP-1 therapy. Its general advice applies as well: regular small meals, and no large ones.

Heartburn that doesn’t ease, or that comes with severe belly pain, is a reason to call your provider. Ask before adding an antacid or other heartburn medicine, since slower stomach emptying can change how oral medicines are absorbed, per Zepbound’s label.

Constipation

What helps constipation on a GLP-1?

Start early: the 2025 joint nutrition advisory says constipation is common with weight loss and should be managed proactively. It affected 11% to 17% of people on Zepbound and 24% on Wegovy, versus 5% and 11% on placebo.

Constipation on a GLP-1: the steps the 2025 joint nutrition advisory lists, in order
StepWhat the advisory says
1. Fluids and food fiberDrink adequate fluids and get fiber from food. Add it gradually, for example prunes or other dried fruit.
2. Easy, watery foodsFoods that flow easily, with more water and fewer calories, such as certain fruits and vegetables, can help your stomach empty faster.
3. MagnesiumDaily magnesium, adjusted to keep bowel movements regular. Magnesium citrate is effective and well tolerated.
4. Other optionsFiber supplements, polyethylene glycol 3350 (a laxative), and stool softeners to avoid straining.

Ask your provider or pharmacist before starting a supplement or laxative, especially magnesium if you have kidney disease.

Severe constipation needs a call. Both labels list reports from after approval of severe constipation, including fecal impaction, and of ileus and intestinal obstruction, which are blockages of the bowel.

Get help

When is a GLP-1 stomach side effect an emergency?

Severe belly pain that won’t go away, sometimes spreading to your back, can be pancreatitis: Zepbound’s label says to stop the medicine and contact your provider. Vomiting or diarrhea that won’t stop can dehydrate you and injure your kidneys.

GLP-1 stomach warning signs and what to do, from the Zepbound prescribing information (sections 5, 6 and 17) and the Wegovy prescribing information (sections 5 and 6)
If you notice…It can be a sign ofWhat to do
Severe belly pain that may spread to your back, with or without nausea or vomitingPancreatitis, an inflamed pancreasStop the medicine and contact your provider right away
Nausea, vomiting or diarrhea that won’t stopDehydration, which can lead to kidney injuryDrink fluids and contact your provider promptly
Severe or lasting stomach symptoms of any kindA severe stomach reaction: 1.7% to 3.1% on Zepbound (1% on placebo) and 4.1% on Wegovy (0.9%)Contact your provider
Severe constipationFecal impaction; bowel blockages (ileus, intestinal obstruction) have also been reportedContact your provider
Pain in your upper belly, fever, yellowing of your skin or eyes, or clay-colored stoolsGallbladder disease: inflamed gallbladder (cholecystitis) in 0.7% on Zepbound vs 0.2% on placeboTell your provider right away
A planned surgery, or a procedure with anesthesia or deep sedationFood left in the stomach can be inhaled (rare reports of pulmonary aspiration)Tell the care team you take a GLP-1 medicine, before the procedure

“Instruct patients to discontinue ZEPBOUND promptly and contact their healthcare provider if pancreatitis is suspected.”

Eli Lilly and Company, Zepbound (tirzepatide) prescribing information, revised August 2026

Can’t reach your provider and symptoms are severe? Go to urgent care or an emergency room. You can report a side effect to the FDA through MedWatch or at 1-800-FDA-1088.

Compounded GLP-1s

Do compounded GLP-1s cause more stomach side effects?

No trial has measured that: compounded tirzepatide and semaglutide aren’t FDA-approved and weren’t studied in the label trials. The FDA has warned about dosing errors: some patients took 5 to 20 times the intended dose of compounded semaglutide by mistake.

After those errors, people reported nausea, vomiting and belly pain, as well as fainting, headache, migraine, dehydration, acute pancreatitis and gallstones, and some needed hospital care, the FDA said on July 26, 2024. Mix-ups between milliliters, milligrams and units, and syringes larger than the dose, contributed.

As of May 31, 2026, the FDA had received 990 adverse event reports tied to compounded semaglutide and more than 730 tied to compounded tirzepatide, according to its page on unapproved GLP-1 drugs (content current as of Oct. 1, 2026).

Safety steps for compounded injectable GLP-1 medicines, from the FDA’s alerts and NexLife’s guides
StepWhy it matters
Check your dose in units against your vial’s strengthUnit mix-ups led to overdoses, and the FDA urges patients to ask their provider or compounder how to measure a dose. Our tirzepatide dosage chart and semaglutide dosage chart do the math.
Throw out a multiple-dose vial 28 days after first use, or by its beyond-use date if soonerThe FDA advises it. Storage rules: keeping compounded tirzepatide cold.
Don’t use an injectable GLP-1 that arrives warmThe FDA advises it, along with filling prescriptions at a state-licensed pharmacy.
Took more than prescribed?Call your provider or Poison Help at 1-800-222-1222, or go to the nearest emergency room right away, the labels say. What to do if you took too much tirzepatide.
Watch for recallsCheck lot numbers on our compounded GLP-1 recall page.

NexLife’s orders are filled by two state-licensed 503A pharmacies: Absolute Pharmacy (Lutz, FL) and Boudreaux’s New Drug Store (Lake Charles, LA). More about NexLife’s pharmacy partners.

Tirzepatide or semaglutide

Is tirzepatide or semaglutide easier on the stomach?

The labels can’t settle it: their numbers come from different trials, with different people, doses and schedules. Within each trial, stomach side effects were far more common on the medicine than on placebo.

Stomach side effects and dose steps, from the Zepbound prescribing information (revised August 2026) and the Wegovy prescribing information (revised June 2026). Separate trials: not a head-to-head comparison.
Label factZepbound (tirzepatide)Wegovy (semaglutide)
Any stomach side effect56% vs 30% on placebo73% vs 47% on placebo
Severe stomach side effects1.7% to 3.1% vs 1%4.1% vs 0.9%
Stopped for a stomach side effect1.9% to 4.3% vs 0.5%4.3% vs 0.7%
Starting dose2.5 mg weekly for 4 weeks0.25 mg weekly for 4 weeks
Dose steps2.5 mg at a time, at least 4 weeks apart, up to 15 mg0.5 mg, 1 mg and 1.7 mg, 4 weeks each, then 2.4 mg (or 1.7 mg); the label allows up to 7.2 mg
If a step isn’t toleratedConsider a lower maintenance doseConsider delaying the next step for 4 weeks

Choosing between them? Our tirzepatide vs semaglutide guide compares results, side effects and cost. For the full list of side effects, not just stomach ones, see tirzepatide side effects. The same guide for semaglutide: compounded semaglutide side effects.

Loved by our members

Real stories from NexLife members about their care and service.

A selection of 5-star reviews from Trustpilot, quoted in full as written. Results vary from person to person, and weight loss isn’t guaranteed.

★★★★★TrustScore 4.8 out of 5 on Trustpilot407 reviews as of Nov. 15, 2026 · Read them all ↗

  • ★★★★★Read on Trustpilot ↗

    “Affordable, quick and easy. They could not have made it a smoother less stressful experience.”

    Andisheh K.

  • ★★★★★Read on Trustpilot ↗

    “Great communication. Easy to work with. They work to set you up for success.”

    Anthony C.

  • ★★★★★Read on Trustpilot ↗

    “Fast delivery and easy to get a hold of when needing to talk with someone!”

    Browneyes

  • ★★★★★Read on Trustpilot ↗

    “So happy with NexLife. Communication has been great, I’m recommending them to all my friends.”

    April

  • ★★★★★Read on Trustpilot ↗

    “Excellent visit. Dr. Kennah was very knowledgeable and helpful and answered all my questions.”

    Ethan B.

  • ★★★★★Read on Trustpilot ↗

    “That’s a real site with good prices and plans!”

    Estefany L.

  • ★★★★★Read on Trustpilot ↗

    “Great service and excellent communication!”

    Gabrielle D.

  • ★★★★★Read on Trustpilot ↗

    “Easy and pricing not bad! Customer service was helpful in answering my questions.”

    Lyndy T.

  • ★★★★★Read on Trustpilot ↗

    “Good experience, great team”

    Mai S.

  • ★★★★★Read on Trustpilot ↗

    “Great communciation and was fast and reliable”

    Kiki

  • ★★★★★Read on Trustpilot ↗

    “Very happy so far”

    Tammy E.

  • ★★★★★Read on Trustpilot ↗

    “Fast service great communication!! Willing to work with you!”

    Bon

Names are shortened for privacy. Reviews are members’ opinions, not medical advice.

What would you pay with NexLife?

Tap where you are now. We’ll show your NexLife price next to it, or tell you we’ll match it.

Pick one above to see your price.

Check my eligibility
Not today?

Prices from each provider’s own site, checked Nov. 1, 2026. Brand-name and compounded medications are different products: compounded medications aren’t FDA-approved, and a provider prescribes one only when it offers a significant difference for you. Price Match Guarantee† terms apply.

What does NexLife cost?
One flat price at every dose.

No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†

Illustration of a compounded tirzepatide vialGIP + GLP-1

12-month plan $115/mo

Tirzepatide

Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan, $1,380 paid upfront; $129/mo month to month, billed monthly.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Illustration of a compounded semaglutide vialGLP-1

12-month plan $95/mo

Semaglutide

Weekly GLP-1. Care, coaching and shipping included. On a 12-month plan, $1,140 paid upfront; $109/mo month to month, billed monthly.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

TrustScore 4.8 out of 5 on Trustpilot 407 reviews as of Nov. 15, 2026 · Read them all ↗

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms

The NexLife Price Match Guarantee†

Paying less elsewhere?
Keep your price. Upgrade your care.

Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.

  1. 1Send a receipt from the last 60 days
  2. 2A NexLife provider reviews your prescription
  3. 3Pay your matched price, at every dose
Switch and keep my price

Locked while your plan is activeSame price at every doseNo membership fee

†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.

GLP-1 stomach side effects: your questions

Fair questions about NexLife

Will my price go up with my dose?
No. You pay the same at every dose.
What if I’m not prescribed?
You aren’t charged for medication.
Can I cancel?
Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
Do I need insurance?
No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.

What are the most common GLP-1 stomach side effects?

Nausea, diarrhea, constipation and vomiting. On Zepbound’s label, nausea affected 25% to 29% of people and diarrhea 19% to 23%, versus 8% on placebo for each. On Wegovy’s, nausea affected 44% and diarrhea 30%, versus 16% for each. Burping, indigestion, reflux, gas and bloating are less common. Most started while the dose was going up.

How long does GLP-1 diarrhea last?

Neither label gives a typical number of days. On Zepbound, most nausea, vomiting and diarrhea happened while the dose was rising and decreased over time, and Wegovy’s stomach side effects were most often reported during dose increases. Drink enough fluids meanwhile. If diarrhea won’t stop, contact your provider promptly: dehydration can lead to kidney injury, both labels warn.

What helps nausea on a GLP-1?

Eat a small breakfast, then small meals every 3 to 4 hours, and drink enough fluids, the 2025 joint nutrition advisory suggests. Avoid large or high-fat meals, keep alcohol to a minimum, and try ginger or peppermint tea. If nausea doesn’t ease, ask your provider about anti-nausea medicine or a slower dose schedule.

Why do GLP-1s cause sulfur burps?

Burping is a listed side effect: 4% to 5% on Zepbound and 7% on Wegovy, versus 1% and under 1% on placebo. The labels don’t give a separate figure for sulfur-smelling burps, and no label or study we found explains the smell. Both medicines slow stomach emptying, which the 2025 advisory links to bloating and fullness. Smaller meals, fewer high-fat foods and very little alcohol are its general steps for stomach symptoms.

Can GLP-1 medicines cause acid reflux or heartburn?

Yes, in a minority of people. Acid reflux (GERD) affected 4% to 5% on Zepbound and 5% on Wegovy, versus 2% and 3% on placebo, and indigestion 9% to 10% and 9%. The 2025 advisory says alcohol may worsen reflux on GLP-1 therapy. Contact your provider if heartburn is severe or doesn’t ease.

What can I take for constipation on a GLP-1?

Start with fluids and fiber from food, added slowly, such as prunes or other dried fruit. If that isn’t enough, the 2025 advisory lists daily magnesium, such as magnesium citrate, fiber supplements, polyethylene glycol 3350 and stool softeners. Ask your provider or pharmacist before starting one, especially if you have kidney disease. Severe constipation is a reason to call your provider.

When is a GLP-1 stomach side effect an emergency?

Severe belly pain that won’t go away, sometimes spreading to your back, with or without vomiting, can be pancreatitis: stop the medicine and contact your provider right away, Zepbound’s label says. Vomiting or diarrhea that won’t stop can dehydrate you and injure your kidneys. Can’t reach your provider and symptoms are severe? Go to urgent care or an emergency room. Tell any surgical team you take a GLP-1 before anesthesia or sedation.

Does compounded tirzepatide or semaglutide cause more stomach side effects?

No trial has compared them. Compounded versions aren’t FDA-approved and weren’t studied in the label trials. The FDA has reported dosing errors with compounded semaglutide, some 5 to 20 times the intended dose, followed by nausea, vomiting, belly pain and hospital stays. Check your dose in units against your vial’s strength, and ask if a number doesn’t match.

Important safety information

Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). The most common side effects include nausea, diarrhea, vomiting, constipation and stomach pain.

Read the full safety information

In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. The FDA warned on Nov. 9, 2026, that GLP-1 medicines may raise the risk of NAION, a rare eye condition that can cause sudden vision loss in one eye; call your provider right away if that happens (FDA). Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.

Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.

This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.

About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.

“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”

U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers

Who wrote and medically reviewed this page?

Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine (American Board of Emergency Medicine) · NPI 1144260043

Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.

NexLife Medical TeamWrites and updates NexLife’s guides

Checked every number against the Zepbound (August 2026) and Wegovy (June 2026) prescribing information, the 2025 joint nutrition advisory and the FDA’s compounding alerts.

Paying less elsewhere? We match it.†

Questions don’t wait for office hours. Neither do we.

Compounded tirzepatide $115 a month on a 12-month plan, or $129 month to month, at every dose, with real people on call 24/7.

4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026) · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified

Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.

  1. 1
    Tell us about you

    Start online with your health history.

  2. 2
    A licensed provider decides

    Online, following your state’s rules. You’re prescribed only if treatment is right for you.

  3. 3
    We ship it, then stay with you

    Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.

Sources

  1. Eli Lilly and Company. Zepbound (tirzepatide) prescribing information, revised August 2026: Table 1 and sections 2.1, 5.2, 5.3, 5.4, 5.5, 5.9, 6.1, 6.2, 12.2 and 17. Read Nov. 15, 2026.
  2. Novo Nordisk, via Drugs@FDA. Wegovy (semaglutide) prescribing information, revised June 2026: Table 3 and sections 2.2, 5.5, 5.6, 5.10, 6.1 and 6.2. Read Nov. 15, 2026.
  3. Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association and The Obesity Society. The American Journal of Clinical Nutrition, 2025;122:344–367, co-published in Obesity. Read Nov. 15, 2026.
  4. U.S. Food and Drug Administration. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024. Read Nov. 15, 2026.
  5. U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. Content current as of Oct. 1, 2026. Read Nov. 15, 2026.
  6. U.S. Food and Drug Administration. MedWatch: report a problem.
  7. NexLife. Compounded tirzepatide plans.
  8. LegitScript. LegitScript certification record for NexLife.us.
  9. NexLife. Compounded semaglutide plans.
  10. Ro: weight loss program pricing. Checked Nov. 15, 2026.
  11. Hims: Zepbound KwikPen. Checked Nov. 1, 2026.
  12. Hims: Wegovy pill and pen, with membership. Checked Nov. 15, 2026.
  13. Mochi Health: FAQs (membership and medication prices). Checked Nov. 15, 2026.
  14. Embody: compounded tirzepatide, one-month supply. Checked Nov. 1, 2026.
  15. Embody: compounded semaglutide, one-month supply. Checked Nov. 1, 2026.
  16. U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. Read Nov. 15, 2026.